UnitedHealth Group (UNH) Is Among Billionaire Coleman’s Top Picks - InvestingChannel

UnitedHealth Group (UNH) Is Among Billionaire Coleman’s Top Picks

We recently compiled a list of the Tech Billionaire Chase Coleman’s Top 10 Stock Picks. In this article, we are going to take a look at where UnitedHealth Group Inc. (NYSE:UNH) stands against the other top stock picks of Tech Billionaire Chase Coleman.

“Tiger cub” Chase Coleman continues to shape the investment landscape with his strategic portfolio decisions. His New York-based investment firm, Tiger Global Management, helped him carve his own path in the financial world and distinguish himself as one of the most successful protegees of Julian Robertson. Previously, Coleman held the position of technology analyst at Tiger Management. Since its foundation in 2001, carrying forward Robertson’s legacy, Tiger Global Management has consistently outperformed market benchmarks.

Focusing mainly on the tech sector, with “headliners” such as Faceabook, Tiger Global led all venture capital firms in raised capital between 2007 and 2017. Additionally, in 2020, the firm generated $10.4 billion in profits for its investors, securing the top spot among hedge funds on LCH Investments’ annual list of world’s greatest hedge fund managers. When the tech sector faced a major downturn in 2022, Tiger Global’s portfolio, which was heavily invested in technology, took a significant hit. The bold strategy of sticking to high-growth technology firms paid off, as the firm’s equity portfolio recovered and showed steady gains in the following years.

READ ALSO: Tiger Global’s 15 Long-Term Stock Picks and 10 Best Growth Stocks To Invest In Now

As of the end of the third quarter of 2024, Tiger Global’s holdings continue to reflect Coleman’s emphasis on the tech sector, with 45 holdings where technology stocks dominate 52.37% of the portfolio, along with concentrations in communication services, healthcare, and financial services. Despite a challenging global environment, the fund has maintained steady growth, increasing its value by over 1.08%, reaching over $23.4 billion in value.

Chase Coleman’s commitment to identifying high-quality businesses, especially in the tech sector, is reflected in Tiger Global’s top stock picks. These choices highlight a strategy centered on industry leaders and innovative companies with strong growth potential.

Tech Billionaire Chase Coleman's Top 10 Stock Picks Chase Coleman of Tiger Global

Our Methodology

To compile the list of Chase Coleman’s top 10 stock picks, we have looked at Tiger Global Management’s latest 13F filing and identified the largest positions based on their value.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).

UnitedHealth Group Inc. (NYSE:UNH)

Shares held by Tiger Global: 2.37 million

Value of position: $1.38 billion

UnitedHealth Group Inc. (NYSE:UNH) is a diversified healthcare leader, operating two primary brands: UnitedHealthcare, offering health insurance, and Optum, which delivers healthcare services, technology, and pharmacy benefits. With a market cap of $559.88 billion, it is the world’s largest healthcare company by revenue, and a critical player in the U.S. health care system.

Tiger Global Management holds shares of UnitedHealth Group Inc. (NYSE:UNH) valued at $1.38 billion as of the end of September, which accounts for 5.9% of the portfolio. The fund recently increased its position by 1%, reflecting confidence in UNH’s potential for stable returns and future growth.

Due to expanded insurance enrollments in the fall and overall growth across all Optum segments, UnitedHealth Group Inc. (NYSE:UNH)’s recent performance has been robust. Analysts forecast EPS of $27.61 for 2024 and $29.99 for 2025, hinting at steady profitability. The company’s payout ratio of 54.72% supports a $2.10 quarterly dividend, being attractive for income-focused investors.

Considering the forward P/E of 20.41, UnitedHealth offers a reasonable valuation considering its scale and growth. Analysts maintain an average price target of $618.26, with a high of $675, optimistic about the firm’s persistence in capturing market share and delivering earnings growth.

Overall, UNH ranks 6th on our list of Billionaire Chase Coleman’s top stock picks. While we acknowledge the potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UNH but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 10 Companies Hoarding Bitcoin Like There’s No Tomorrow and Wall Street Analysts Can’t Stop Talking About These 10 AI Stocks

Disclosure: None. This article is originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire